openPR Logo
Press release

Investigation announced for Long-Term Investros in Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) shares over potential Wrongdoing

09-29-2022 05:51 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of current long term investors in Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) shares.

An investigation on behalf of current long term investors in Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) shares.

An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Verrica Pharmaceuticals Inc..

Investors who are current long term investors in Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: VRCA stocks follows a lawsuit filed against Verrica Pharmaceuticals Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: VRCA stocks, concerns whether certain Verrica Pharmaceuticals Inc. directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the Eastern District of Pennsylvania the plaintiff alleges that, the Defendants failed to disclose to investors that there were manufacturing deficiencies at the facility where Verrica Pharmaceuticals' contract manufacturer produced bulk solution for VP-102, that these deficiencies were not remediated when Verrica Pharmaceuticals resubmitted its NDA for VP-102, that the foregoing presented significant risks to Verrica Pharmaceuticals obtaining regulatory approval of VP-102, and that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Those who purchased shares of Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long-Term Investros in Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) shares over potential Wrongdoing here

News-ID: 2752848 • Views:

More Releases from Shareholders Foundation

Investigation announced for Investors in shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) over possible Violations of Securities Laws
Investigation announced for Investors in shares of Lifecore Biomedical, Inc. (NA …
An investigation was announced for investors of Lifecore Biomedical, Inc. (NASDAQ: LFCR) shares over potential securities laws violations by Lifecore Biomedical, Inc. Investors who purchased shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Lifecore Biomedical, Inc. regarding its business, its prospects and
Investigation announced for Investors in shares of Designer Brands Inc. (NYSE: DBI) over potential Wrongdoing by certain directors
Investigation announced for Investors in shares of Designer Brands Inc. (NYSE: D …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Designer Brands Inc. Investors who purchased shares of Designer Brands Inc. (NYSE: DBI) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Designer Brands Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders. Columbus,
Lawsuit Alert: Investors who lost money with shares of Innoviz Technologies Ltd. (NASDAQ: INVZ) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with shares of Innoviz Technologies Ltd. …
An investor, who purchased shares of Innoviz Technologies Ltd. (NASDAQ: INVZ), filed a lawsuit over alleged violations of Federal Securities Laws by Innoviz Technologies Ltd. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Innoviz Technologies Ltd. (NASDAQ: INVZ) have certain options and for certain investors are short and strict deadlines running. Deadline: May 14, 2024. NASDAQ: INVZ investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors who lost money with shares of iRobot Corporation (NASDAQ: IRBT)
Lawsuit filed for Investors who lost money with shares of iRobot Corporation (NA …
An investor, who purchased shares of iRobot Corporation (NASDAQ: IRBT), filed a lawsuit over alleged violations of Federal Securities Laws by iRobot Corporation in connection with certain allegedly false and misleading statements. Investors who purchased shares of iRobot Corporation (NASDAQ: IRBT) have certain options and for certain investors are short and strict deadlines running. Deadline: May 7, 2024. NASDAQ: IRBT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)

All 5 Releases


More Releases for Verrica

Lawsuit filed for Investors in shares of Verrica Pharmaceuticals Inc. (NASDAQ: V …
An investor, who purchased shares of Verrica Pharmaceuticals Inc. (NASDAQ: VRCA), filed a lawsuit over alleged Securities Laws violations by Verrica Pharmaceuticals Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) ou have certain options and for certain investors are short and strict deadlines running. Deadline: August 5, 2022. NASDAQ: VRCA investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or
Investigation announced for Investors in shares of Verrica Pharmaceuticals Inc. …
An investigation was announced concerning potential securities laws violations by Verrica Pharmaceuticals Inc. in connection with certain financial statements. Investors who purchased shares of Verrica Pharmaceuticals Inc. (NASDAQ: VRCA), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) concerning whether a
Wart Remover Market Trends, Business Overview, Industry Growth and Forecast to 2 …
The global wart remover market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Warts are skin infections caused by human papillomavirus (HPV). Wart remover is a medication used to treat common skin or plantar warts. The rise in the prevalence of warts is anticipated to drive the growth of the global wart remover market. For instance, according to the data published by National Center for
Warts Therapeutics Market Size, Share & Growth Analysis 2021-2028 By Key Players …
The Warts Therapeutics market Research Report is an In-depth analysis of overall market size, share, trends and growth prospects in the market. The Warts Therapeutics market is a comprehensive analysis of Competitive Landscape and Manufacturing Factor Such as Sales Volume, price, revenue, gross Margin, and Business Developments.to Forecast the market. The Warts Therapeutics Market Analysis Is analysis the correct evaulation and Forecast the future scenario by type and Application to
Verruca Treatment Market Technology, Recent Trends, Future Growth Analysis Forec …
The human papillomavirus causes verrucas, which are tiny, scratchy lumps or growths on your skin (HPV). Almost everyone receives one at some point throughout their lives. They're most common in kids and teenagers. A verruca is a wart on the sole of your foot. Request Sample Copy of Verruca Treatment Market Report: https://www.infinitybusinessinsights.com/request_sample.php?id=573506 Top Key Players Included in Verruca Treatment Market Report: Verrica Pharmaceuticals, RXi Pharmaceuticals, Peritech Pharma, Euro Vital Pharma GmbH,
Deadline on Sept. 14, 2020 in Lawsuit for Investors in shares of Verrica Pharmac …
A deadline is coming up on September 14, 2020 in the lawsuit filed for certain investors of Verrica Pharmaceuticals Inc. (NASDAQ: VRCA). Investors who purchased shares of Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) have certain options and there are strict and short deadlines running. Deadline: September 14, 2020. NASDAQ: VRCA stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to the complaint filed in the U.S District